Dupuytren Contracture

Chapter 75 Dupuytren Contracture




Dupuytren disease is a proliferative fibroplasia of the subcutaneous palmar tissue occurring in the form of nodules and cords that may result in secondary progressive and irreversible finger joint flexion contractures. Other secondary changes include thinning of the overlying subcutaneous fat, adhesion to skin, and later pitting or dimpling of the skin. The lesion activity and the ensuing deformity rate vary considerably. Occasionally, a finger may become markedly flexed within a few weeks or months, but development of severe deformity usually requires several years. In some patients, the lesion progresses steadily, whereas in others, exacerbations and remissions occur; however, regression is rare.


Ectopic Dupuytren disease deposits may occur in a variety of areas (Fig. 75-1). Approximately 5% of patients with Dupuytren contractures have similar lesions in the medial plantar fascia of one or both feet, known as Ledderhose disease, and 3% of patients have plastic penile induration, known as Peyronie disease. Garrod nodules, “knuckle pads” are common on the dorsum of the proximal interphalangeal joints. Patients with these associated findings are considered to have a Dupuytren diathesis and are prone to progressive and recurrent disease.



Commonly occurring in adults in their 40s to 60s, Dupuytren contracture occurs 10 times more frequently in men than in women. According to McFarlane, the disease occurs significantly earlier in men (33 to 63 years old) than in women (46 to 70 years old). It is most common in individuals of Scandinavian and Celtic origin, although it has been reported occasionally in blacks and rarely in Asians. The lesion has been reported to be more frequent and severe in individuals with diabetes mellitus or with epilepsy (42%), and conflicting reports exist concerning the disease in individuals with alcoholism. The involvement, although often bilateral (45%), rarely is symmetrical (Fig. 75-2). Mikkelsen et al. found that mortality may be increased in men who develop the disease before age 60.



Although the causes of this disease are unknown, hand trauma and the type of manual labor performed by an individual may be contributing factors. The presence of hemosiderin in these lesions suggests hemorrhage from tears; however, the nondominant hand is affected as often as the dominant one, making trauma alone an unlikely cause. Occasionally a single injury may precipitate the onset of the disease in genetically susceptible individuals. According to McFarlane, a causal relationship may be assumed if consistent histological changes occur within 2 years after a focal injury in women younger than 50 years of age and men younger than 40 without a strong diathesis for Dupuytren disease. In patients with bilateral disease, the disease should develop in the uninjured hand after age 40 in men and 50 in women.


Evidence also points to heredity as a predisposing factor in Dupuytren disease. The lesion seems to occur earlier and more frequently in some families, and an autosomal dominant pattern has been suggested. Vascular insufficiency and cigarette smoking have been linked to Dupuytren disease as possible causative factors.


The lesion usually begins on the ulnar side of the hand at the distal palmar crease and progresses to involve the ring and little fingers, these being affected more frequently than all other digits combined. Metacarpophalangeal and proximal interphalangeal joint flexion contractures gradually develop; their severity depends on the extent and maturity of the fibroplasia. Discomfort is rare and usually consists of itching or occasional pain early in the development of the nodules.



Pathogenesis


The cause of Dupuytren disease is unknown; however, much has been discovered about the cellular and connective tissue changes that occur with this disorder. Although it has some similarity to malignant tumors, it is a benign process. Dupuytren begins with increased fibroblast proliferation followed by type 3 collagen deposition that results in uncontrolled palmar fascia growth ultimately causing flexion contractures. The exact reasons for this are unknown. Dupuytren disease has been compared with wound healing in that myofibroblasts, which produce collagen 3, are dominant in both granulation tissue and Dupuytren tissue. In addition, growth factors and their receptors have been shown to have increased expression in diseased fascia, especially transforming growth factor-β and basic fibroblast growth factor. Transforming growth factor-β has been shown to induce differentiation of fibroblasts into myofibroblasts. An increase in glycosaminoglycans, matrix metalloproteinase activity, the presence of fibrofatty tissue between the skin and fascia, trauma, and microtrauma caused by free radicals also have been theorized as playing a role in the development of Dupuytren contracture. A new DNA study is underway to try to identify a responsible gene(s).


Dupuytren disease progresses through several stages: proliferative, involutional, and residual. In the proliferative stage, nodules, composed of type III collagen and fibroblasts, develop and expand to displace the subcutaneous tissue and fuse to the skin. The nodules typically appear at the distal palmar crease over the metacarpophalangeal joints and distally over the proximal interphalangeal joints but not over the distal interphalangeal joints. They eventually stop growing and begin to contract in the involutional stage. Stress alignment of the fibroblasts occurs, and more collagen is produced. Myofibroblasts then replace the fibroblasts as the predominant cell type, producing type III collagen and causing contraction. Nodule contraction places tension on the normal fascia proximally, producing fascial hypertrophy and nodule-cord units. In the residual phase, the nodules decrease in size and may become acellular fibrous cords. Contractures of the metacarpophalangeal and proximal interphalangeal joints and displacement of digital neurovascular bundles result from predictable patterns of fascial cord involvement.


The fascial structures that may become involved in the fibroproliferative process have been clearly outlined by McFarlane (Fig. 75-3). Thomine described a longitudinally oriented fascia located dorsal to the neurovascular bundle, which he termed the retrovascular cord. This structure often is involved in the disease and may be implicated as a cause for recurrent proximal interphalangeal contractures. The Cleland ligament generally is believed to be spared. The pretendinous cord nearly always is responsible for primary contracture of the metacarpophalangeal joint. It may attach to the distal palmar crease skin, base of the proximal phalanx, or the tendon sheath at this level, or it may extend to attach to the flexor tendon sheath over the middle phalanx or the skin in this area. A spiral cord occurs when four normally existing structures (pretendinous band, spiral band, lateral digital sheet, and Grayson ligament) become diseased. The spiral cord runs dorsal to the neurovascular bundle proximally and volar to it distally. When the spiral cord is contracted, the neurovascular bundle is drawn toward the midline of the finger (Fig. 75-4). Neurovascular displacement is found most commonly on the ulnar aspect of the little and ring fingers, and tedious dissection is required to prevent digital nerve injury.




The lateral digital cord may extend distally and contribute to a flexion contracture of the distal interphalangeal joint. The plane between this cord and the overlying skin is minimal and must be developed sharply. The retrovascular cord is not believed to contribute significantly to flexion contracture of the proximal interphalangeal joint; however, it may be responsible for some residual flexion contracture or recurrence if not excised.


Metacarpophalangeal and distal interphalangeal joint contractures seem to result from pretendinous and lateral cord development. Proximal interphalangeal joint contractures may develop from isolated digital cords, however, in addition to central, spiral, or retrovascular cords (Fig. 75-5). The diseased tissue in this unusual form of Dupuytren contracture most commonly affects the small finger; however, any digit may be involved. The cord originates from the periosteum of the proximal phalanx and fascia overlying the intrinsic muscles and distally courses dorsal to the neurovascular bundles, inserting into the middle phalanx or the overlying flexor tendon sheath volar to the neurovascular bundles. This digital cord frequently displaces the neurovascular bundle superficially to the midline of the finger, similar to a spiral cord.



Skoog suggested that of the palmar fascia components, only the longitudinal pretendinous bands are involved and that the superficial transverse palmar ligaments are always spared. We agree with McFarlane, however, that the superficial transverse ligaments, in addition to natatory cord prominence, are frequently involved and require excision in symptomatic thumb web space contractures.



Prognosis


The prognosis in Dupuytren contracture seems to depend on the following factors, which may determine the appropriate intervention:



1. Heredity. A family history of the disease indicates that the lesion is likely to progress more rapidly than usual, especially if the onset is early.


2. Sex. The lesion usually begins later and progresses more slowly in women, who often accommodate better to the resulting deformity; however, long-term results after operation are worse in women than in men, with postoperative flare reaction being twice as likely.


3. Epilepsy. Despite earlier statements positively associating Dupuytren contracture with epilepsy, Geoghegan et al. concluded that neither epilepsy nor antiepileptic medications were associated with the disease.


4. Diabetes mellitus. Diabetes mellitus is a risk factor for Dupuytren disease, especially in patients requiring medical management compared with patients with diet-controlled diabetes mellitus. According to Geoghegan et al., patients taking insulin were more likely to have Dupuytren disease than patients taking metformin or sulfonylureas.


5. Alcoholism or smoking. The lesions are more severe, progress more rapidly, and recur more frequently when associated with these conditions. Godtfredsen et al. found a dose-dependent relationship to alcohol intake and smoking and concluded that the combination of these two factors conveys a high risk for the development of Dupuytren disease.


6. Location and extent of disease. When the disease is bilateral and especially when it is associated with knuckle pads and nodules in the plantar fascia, progression is more rapid, and recurrence is more frequent. Progression is more rapid on the ulnar side of the hand.


7. Behavior of disease. How the disease has behaved in the past, whether treated or not, is an indication of its probable behavior in the future.



Treatment


Various nonoperative treatment regimens for Dupuytren disease continue to focus on the fundamental disease histopathology. Nodule-derived fibroblast contractile properties were shown by Bisson et al. to be greater than those of cord-derived fibroblasts, and both of these fibroblast lines had significantly greater force generation than carpal tunnel ligament fibroblasts. Ketchum and Donahue found that after an average of 3.2 injections per nodule of triamcinolone acetonide, 97% of 75 hands had softening or flattening of the nodules. Although complete resolution of the disease was rare, only half of the patients had nodule reactivation within 3 years after the injections.


Clinical trials evaluating clostridial collagenase injections as a nonoperative treatment have indicated prompt and impressive metacarpophalangeal and proximal interphalangeal joint contracture release. Badalamente et al. reported on the safety and efficacy of this enzymatic degradation in studies, including a randomized placebo-controlled study in which Hurst et al. reported contracture reduction to 0 to 5 degrees in 77% of metacarpophalangeal joint and 40% of proximal interphalangeal joint contractures in 204 joints receiving collagenase injections. Despite these results being significantly better than in the 104 joint placebo group, the 30-day outcome did not allow the authors to comment in regard to recurrence. In a previous 2-month follow-up study, similar results were achieved compared with placebo and only 5 of 62 joints had recurrence. Transient side effects included localized swelling, pain, bruising, pruritus, regional lymph node enlargement, and tenderness; however, permanent adverse serious side effects were rare, aside from two flexor tendon ruptures in the prior study. We have no experience with collagenase injections. Best results are obtained in patients with a well-defined palpable cord that is located away from the flexor tendon. Collagenase injection may be contraindicated in patients who are on anticoagulation, have lymphedema, lymph node surgery, or implants.

Stay updated, free articles. Join our Telegram channel

Jun 5, 2016 | Posted by in ORTHOPEDIC | Comments Off on Dupuytren Contracture

Full access? Get Clinical Tree

Get Clinical Tree app for offline access